Inventor profile of:

Chuo CHEN

City:

Dallas, Texas

Country:

United States

Published Applications:

33

Last publication date:

2026-02-12

Top Assignees for applications by Chuo CHEN

The entities that hold a legal rights for patent applications filed by inventor CHEN Chuo:

Recent patent applications by CHEN Chuo

Chuo CHEN from Dallas, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-12
US20260042737A1
Chemistry; metallurgy

QUINOLINE cGAS ANTAGONIST COMPOUNDS

#2 | 2025-05-29
US20250170120A1
Human necessities

ALLOSTERIC STING MODULATORS AND METHODS OF USE

#3 | 2025-04-10
US20250115579A1
Chemistry; metallurgy

QUINOLINE cGAS ANTAGONIST COMPOUNDS

#4 | 2025-04-10
US20250115564A1
Chemistry; metallurgy

cGAS ANTAGONIST COMPOUNDS

#5 | 2024-03-21
US20240092760A1
Chemistry; metallurgy

Quinoline cGAS antagonist compounds

#6 | 2024-02-08
US20240043393A1
Chemistry; metallurgy

cGAS antagonist compounds

#7 | 2024-01-04
US20240002346A1
Chemistry; metallurgy

Quinoline cGAS antagonist compounds

#8 | 2023-11-09
US20230357158A1
Chemistry; metallurgy

Quinoline cGAS antagonist compounds

#9 | 2023-03-16
US20230081291A1
Chemistry; metallurgy

Quinoline cGAS antagonist compounds

#10 | 2022-11-10
US20220356158A1
Chemistry; metallurgy

CGAS antagonist compounds

#11 | 2022-10-27
US20220340613A1
Chemistry; metallurgy

CYCLIC DI-NUCLEOTIDE COMPOUNDS AND METHODS OF USE

#12 | 2022-04-07
US20220105198A1
Human necessities

Antibody-sting agonist conjugates and their use in immunotherapy

#13 | 2022-03-31
US20220098196A1
Chemistry; metallurgy

TRAPPING-FREE PARP INHIBITORS

#14 | 2021-09-23
US20210290774A1
Human necessities

Antibody-sting agonist conjugates and their use in immunotherapy

#15 | 2021-01-21
US20210015941A1
Human necessities

Antibody-STING agonist conjugates and their use in immunotherapy

#16 | 2020-10-01
US20200308216A1
Chemistry; metallurgy

Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

#17 | 2020-05-07
US20200140477A1
Chemistry; metallurgy

Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

#18 | 2020-04-02
US20200102342A1
Chemistry; metallurgy

Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

#19 | 2020-01-09
US20200010501A1
Chemistry; metallurgy

Cyclic di-nucleotide compounds and methods of use

#20 | 2019-08-29
US20190263851A1
Chemistry; metallurgy

Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

#21 | 2019-07-04
US20190202804A1
Chemistry; metallurgy

Disubstituted and trisubstituted 1,2,3-triazoles as Wnt inhibitors

#22 | 2018-09-27
US20180271848A1
Human necessities

Indolinyl-sulfonamide inhibitors of tankyrase and methods of use thereof

#23 | 2018-08-16
US20180230177A1
Chemistry; metallurgy

Cyclic di-nucleotide compounds and methods of use

#24 | 2018-08-16
US20180230115A1
Chemistry; metallurgy

cGAS antagonist compounds

#25 | 2017-10-26
US20170304240A1
Human necessities

Compounds supports hematopoietic stem cells and red blood cells

#26 | 2017-10-19
US20170296655A1
Human necessities

Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

#27 | 2016-04-28
US20160115177A1
Chemistry; metallurgy

Highly potent inhibitors of porcupine

#28 | 2015-12-31
US20150374696A1
Human necessities

WNT PROTEIN SIGNALLING INHIBITORS

#29 | 2015-12-03
US20150343056A1
Human necessities

Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway

#30 | 2015-06-11
US20150157633A1
Human necessities

WNT PROTEIN SIGNALLING INHIBITORS

#31 | 2014-02-06
US20140038922A1
Chemistry; metallurgy

WNT protein signalling inhibitors

#32 | 2011-06-09
US20110136813A1
Human necessities

Wnt protein signalling inhibitors

#33 | 2007-11-15
US20070264623A1
Performing operations; transporting

Nanosensors

InventorID:

642302 ⎘